Abstract
Get full access to this article
View all access options for this article.
References
1.Pfizer DMD Gene Therapy Team . Letter to Parent Project Muscular Dystrophy . May 7, 2024 . Available from: https://www.parentprojectmd.org/wp-content/uploads/2024/05/Pfizer-DMD-PAG-Letter_Final.pdf [Last accessed:
May 11 , 2024
].
2.Pfizer . U.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B . April 26, 2024 . Available from: https://www.pfizer.com/news/press-release/press-release-detail/us-fda-approves-pfizers-beqveztm-fidanacogene-elaparvovec [Last accessed:
May 11 , 2024
].
3.
Philippidis
A
. Regeneron, Mammoth Launch In Vivo CRISPR Gene Editing Collaboration . Genetic Engineering & Biotechnology News. April 25, 2024 . Available from: https://www.genengnews.com/topics/genome-editing/regeneron-mammoth-launch-in-vivo-crispr-gene-editing-collaboration/ [Last accessed:
May 11 , 2024
].
4.Regeneron Pharmaceuticals and Mammoth Biosciences . Regeneron and Mammoth Biosciences Collaborate to Pursue Next-Generation CRISPR-Based Gene Editing for Multiple Diseases . April 25, 2024 . Available from: https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-mammoth-biosciences-collaborate-pursue-next [Last accessed:
May 11 , 2024
].
5.Regeneron Pharmaceuticals . Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Levels in a Child with Profound Genetic Deafness within 24 Weeks and Initial Hearing Improvements in a Second Child at 6 Weeks . May 8, 2024 . Available from: https://investor.regeneron.com/news-releases/news-release-details/latest-db-oto-results-show-dramatically-improved-hearing-normal [Last accessed:
May 13 , 2024
].
6.Latus Bio . Latus Launches with State-of-the-Art Gene Therapy Development Technologies, Two Lead Product Candidates, and an Initial $54 Million in Series A Financing . May 2, 2024 . Available from: https://www.businesswire.com/news/home/20240502968167/en/Latus-Launches-with-State-of-the-Art-Gene-Therapy-Development-Technologies-Two-Lead-Product-Candidates-and-an-Initial-54-Million-in-Series-A-Financing [Last accessed:
May 12 , 2024
].
7.Bluebird Bio . Bluebird bio Announces Completion of First Cell Collection for LYFGENIA™ Gene Therapy . May 6, 2024 . Available from: https://investor.bluebirdbio.com/news-releases/news-release-details/bluebird-bio-announces-completion-first-cell-collection [Last accessed:
May 14 , 2024
].
8.Institut de la Vision (Vision Institute), WhiteLab Genomics, and ADLIN Science . GEAR: A major gene therapy . May 2, 2024 . Available from: https://www.institut-vision.org/en/news/gear-major-gene-therapy-project [Last accessed:
May 12 , 2024
].